Testosterone and "Low T"

What It Covers

This episode examines how testosterone replacement therapy transformed from rare medical treatment for serious testicular dysfunction into a mainstream lifestyle intervention used by 14% of men over 40. It traces pharmaceutical marketing that rebranded normal aging as "Low T," creating a billion-dollar industry despite limited evidence of benefits beyond sexual function and mood.

Key Questions Answered

• •Marketing Disease Creation: Pharmaceutical company Solvay invented "Low T" in 2000 to expand Androgel's market beyond rare hypogonadism cases. They sponsored the ADAM questionnaire (drafted in 20 minutes), funded studies showing 40% of men over 45 had "low testosterone," and ran awareness campaigns generating $1.3 billion in 2012 sales while avoiding FDA restrictions by not naming the drug directly.
• •Normal Range Manipulation: Testosterone levels between 250-800 nanograms per deciliter qualify as normal, varying dramatically by age, time of day, and recent experiences. The "winner effect" shows testosterone rises 15-35% after success (sports wins, work achievements) and drops similarly after losses. This natural fluctuation means men can test "low" one day and normal days later, enabling easy diagnosis.
• •Limited Clinical Benefits: A 2016 New England Journal of Medicine trial with 790 men over 65 found testosterone replacement produced moderate improvements in sexual function and mood but showed no benefits for vitality, energy levels, or walking distance. The study contradicted marketing promises of comprehensive life transformation, revealing TRT addresses only narrow symptom categories in older men.
• •Telehealth Expansion Risks: Online men's health companies (Hims, Hone, Maximus) now provide TRT prescriptions within 30 minutes via cash-only assessments without comprehensive medical evaluation. This bypasses proper diagnosis of underlying conditions like depression or obesity that may cause low testosterone as a symptom rather than root cause, treating numbers instead of actual health problems.
• •Permanent Physiological Changes: Taking exogenous testosterone causes testicles to atrophy since the body stops producing its own supply. Some men cannot restart natural production after stopping TRT, requiring lifelong treatment. The therapy also amplifies aggression, reduces empathy and patience, and eliminates mental space previously occupied by sexual thoughts, fundamentally altering personality and social functioning beyond physical effects.